ALPS Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-145,354
Closed -$458K 906
2020
Q3
$458K Sell
145,354
-13,627
-9% -$42.9K 0.01% 469
2020
Q2
$463K Sell
158,981
-48,617
-23% -$142K 0.01% 455
2020
Q1
$585K Sell
207,598
-24,202
-10% -$68.2K 0.01% 418
2019
Q4
$752K Buy
231,800
+4,118
+2% +$13.4K 0.01% 434
2019
Q3
$492K Sell
227,682
-24,829
-10% -$53.7K ﹤0.01% 500
2019
Q2
$793K Sell
252,511
-100,077
-28% -$314K 0.01% 379
2019
Q1
$1.31M Buy
352,588
+15,222
+5% +$56.6K 0.01% 274
2018
Q4
$978K Buy
337,366
+80,063
+31% +$232K 0.01% 308
2018
Q3
$677K Sell
257,303
-109,922
-30% -$289K ﹤0.01% 485
2018
Q2
$859K Buy
367,225
+4,631
+1% +$10.8K 0.01% 370
2018
Q1
$1.07M Buy
362,594
+45,449
+14% +$134K 0.01% 301
2017
Q4
$869K Sell
317,145
-143,801
-31% -$394K 0.01% 284
2017
Q3
$1.56M Buy
460,946
+179,300
+64% +$608K 0.01% 204
2017
Q2
$696K Buy
281,646
+25,472
+10% +$62.9K ﹤0.01% 295
2017
Q1
$582K Buy
256,174
+30,956
+14% +$70.3K ﹤0.01% 294
2016
Q4
$477K Sell
225,218
-13,833
-6% -$29.3K ﹤0.01% 443
2016
Q3
$801K Sell
239,051
-129,043
-35% -$432K 0.01% 231
2016
Q2
$1.16M Buy
368,094
+37,187
+11% +$117K 0.01% 203
2016
Q1
$1.1M Buy
330,907
+22,464
+7% +$74.8K 0.01% 184
2015
Q4
$1.09M Sell
308,443
-41,493
-12% -$147K 0.01% 215
2015
Q3
$17.6K Buy
349,936
+114,217
+48% +$5.75K 0.02% 179
2015
Q2
$1.52M Buy
235,719
+83,094
+54% +$534K 0.01% 184
2015
Q1
$1.07M Buy
152,625
+86,043
+129% +$605K 0.01% 184
2014
Q4
$513K Sell
66,582
-3,796
-5% -$29.2K ﹤0.01% 455
2014
Q3
$526K Buy
70,378
+840
+1% +$6.28K ﹤0.01% 553
2014
Q2
$673K Buy
69,538
+1,772
+3% +$17.2K 0.01% 235
2014
Q1
$563K Buy
67,766
+7,196
+12% +$59.8K 0.01% 462
2013
Q4
$551K Buy
60,570
+29,410
+94% +$268K 0.01% 275
2013
Q3
$248K Buy
+31,160
New +$248K ﹤0.01% 480